Indefinite Delivery Contract SPE2D018D0004

Golden State Medical Supply, Inc. (Camarillo, California) holds a single-award Indefinite Delivery Contract with the Medical Supply Chain, a Defense agency component, with a ceiling value of $6,883,760.65 and an ultimate completion date of November 15, 2027. This contract, awarded November 16, 2017, utilizes no set-aside designation and operates under a firm fixed-price structure. The contract encompasses the manufacture and distribution of pharmaceutical products to support federal defense and healthcare operations. Performance is conducted at the contractor's facility in Camarillo, California, positioning Golden State Medical Supply as a critical pharmaceutical supplier for the Department of Defense and related federal healthcare systems requiring consistent inventory management and rapid fulfillment capabilities.

The delivery orders issued under this indefinite delivery vehicle demonstrate a diverse pharmaceutical product portfolio spanning multiple therapeutic categories including antibiotics (ciprofloxacin, levofloxacin, metronidazole, clindamycin, moxifloxacin), antivirals (valacyclovir, acyclovir), cardiovascular agents (nitroglycerin), antifungals (ketoconazole), cough suppressants (benzonatate), antihistamines (olopatadine), topical medications (lidocaine ointment, fluticasone propionate spray), and other essential prescription medications. Recent delivery orders issued between July and September 2025 range from $20 to $2,225.04 in individual ceiling values, with completion dates typically within 1–14 days of award, reflecting the emergency supply and replenishment nature of this contract vehicle. The cumulative delivery order activity demonstrates sustained demand for pharmaceutical supplies across federal healthcare networks, with the contractor maintaining consistent capacity to fulfill time-sensitive procurement requirements across multiple medication categories and dosage forms.